A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/1997
12/23/1997	US5700806 Farnesyl protein transferase enzyme inhibitor, antitumor agents
12/23/1997	US5700804 Inhibitors of plasminogen activator inhibitors
12/23/1997	US5700801 Antiinflammatory agents, bone disorders
12/23/1997	US5700791 Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof
12/23/1997	US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines
12/23/1997	US5700649 Method of detection of urinary tumor associated antigen
12/23/1997	US5700638 Cell death regulator
12/23/1997	US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor
12/23/1997	CA2103324C N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
12/19/1997	CA2208136A1 Inhibition of abnormal accumulation of extracellular matrices
12/18/1997	WO1997047744A2 T-cell selective interleukin-4 agonists
12/18/1997	WO1997047659A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
12/18/1997	WO1997047638A1 Cellular injury response element and uses thereof
12/18/1997	WO1997047611A1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents
12/18/1997	WO1997047577A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them
12/18/1997	WO1997047317A1 Combination of a somatostatin analogue and a rapamycin
12/18/1997	WO1997047303A1 Substituted benzylidene indenyl formamides, acetamides and propionamides
12/18/1997	WO1997047296A2 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
12/18/1997	WO1997047271A2 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	WO1997035982A3 Monocyte chemotactic protein-5 materials and methods
12/18/1997	WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
12/18/1997	WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells
12/18/1997	DE19724546A1 Composition for treating cancer, containing proteins and/or peptide(s)
12/18/1997	CA2258553A1 Cellular injury response element and uses thereof
12/18/1997	CA2258082A1 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	CA2257422A1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents
12/18/1997	CA2256459A1 T-cell selective interleukin-4 agonists
12/18/1997	CA2207886A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
12/17/1997	EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family
12/17/1997	EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists
12/17/1997	EP0812360A1 Human geranylgeranyl pyrophosphate synthetase
12/17/1997	EP0812356A1 Prostate-specific membrane antigen and uses thereof
12/17/1997	EP0812355A2 Agent for treating tumours and other hyperplasia
12/17/1997	EP0812333A1 Bispecific antibody effective to treat b-cell lymphoma and cell line
12/17/1997	EP0812332A1 AN IMMUNOINTERACTIVE MOLECULE WHICH BINDS THE $i(TIE)2/TEK RECEPTOR EXTRACELLULAR DOMAIN
12/17/1997	EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
12/17/1997	EP0812319A1 2-arylbenzazole compounds
12/17/1997	EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors
12/17/1997	EP0812206A1 Method for stimulating an immune response
12/17/1997	EP0812204A1 Codominance-mediated toxins
12/17/1997	EP0812203A1 Inhibitors of geranylgeranyl-protein transferase
12/17/1997	EP0812199A1 Sphingosine, methylsphingosine and apoptosis
12/17/1997	EP0812192A1 Benzothiopyranoindazoles antitumor agents
12/17/1997	EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
12/17/1997	EP0593601B1 Novel compositions based on taxane class derivatives
12/17/1997	EP0591311B1 Controlled release systems and low dose androgens
12/17/1997	EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
12/17/1997	EP0202276B2 Composition for the treatment of psoriasis
12/17/1997	CN1168143A Antitumor agents isolated from intestinal mucosa, method for their isolation and their application
12/17/1997	CN1168139A Camptothecin derivs. and their mfg. method
12/17/1997	CN1168138A Aryl and heteroaryl purine compounds
12/17/1997	CN1168103A Dermatological use of vitamin D derivs.
12/17/1997	CN1167777A Interferon conjugates
12/17/1997	CN1167759A Substd. 2-naphthoyl guanidines, their preparing method, use and drug contg. them
12/17/1997	CN1167752A Novel retinoids derivs.
12/17/1997	CN1167617A Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
12/17/1997	CN1036718C Method for preparing 19-demethyl steroid compound having thiocarbon chain at 11-beta position
12/16/1997	US5698706 Heterocyclic amides and methods of use
12/16/1997	US5698690 Hydroxamic acid derivatives with tricyclic substitution
12/16/1997	US5698581 Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
12/16/1997	US5698578 Protein kinase C inhibitors
12/16/1997	US5698535 SIN-1A cyclodextrin inclusion complexes
12/16/1997	US5698530 A vaccinia virus into which carcinoembryonic antigen gene is inserteted; induce an active immune response
12/16/1997	US5698529 Chemotherapeutic compositions
12/16/1997	US5698520 Peptide related to human programmed cell death and DNA encoding the same
12/16/1997	US5698445 Human PAK65
12/16/1997	US5698439 Novel malignant cell type markers of the interior nuclear matrix
12/16/1997	US5698428 Human PAK65
12/16/1997	US5698405 Coupling immunogenic agent with a carbohydrate polymer
12/16/1997	US5698201 Method for treatment of antigenically modified polypeptides
12/16/1997	US5698194 Method for making a medicament for treating secondary immunodeficiency
12/16/1997	US5698178 Binding a multidrug transporter protein and an antigen associated with a tumor or infectious agent
12/16/1997	US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent
12/11/1997	WO1997046710A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof
12/11/1997	WO1997046688A1 Lipid kinase
12/11/1997	WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells
12/11/1997	WO1997046683A2 Polynucleotides encoding secreted proteins
12/11/1997	WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins
12/11/1997	WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes
12/11/1997	WO1997046589A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
12/11/1997	WO1997046564A1 Novel water-soluble analogues of 20(s)-camptothecin
12/11/1997	WO1997046563A1 Novel water-soluble c-ring analogues of 20 (s)-camptothecin
12/11/1997	WO1997046562A1 Novel water-soluble c-ring analogues of 20(s)-camptothecin
12/11/1997	WO1997046552A1 1-(1h-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor
12/11/1997	WO1997046551A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/11/1997	WO1997046522A1 Novel vitamin d analogues
12/11/1997	WO1997046259A2 Chimeric toxin for targeted therapy
12/11/1997	WO1997046232A1 7-deoxy-6-substituted paclitaxels
12/11/1997	WO1997046228A1 Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
12/11/1997	WO1997046225A1 Selenophene anti-tumor agents
12/11/1997	CA2257261A1 7-deoxy-6-substituted paclitaxels
12/11/1997	CA2257117A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof
12/11/1997	CA2256522A1 Polynucleotides encoding secreted proteins
12/11/1997	CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells
12/11/1997	CA2254757A1 1-(1h-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor
12/10/1997	EP0811686A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811685A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811616A1 Salts of 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester
12/10/1997	EP0811613A1 Antibiotic Quinolones and derivatives
12/10/1997	EP0811610A1 Ortho-substituted benzoylguanidines process for their preparation, their use as medicament or diagnostic agent and medicaments containing them

1 ... 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 ... 2211